OraSure Technologies (NASDAQ:OSUR – Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Friday.
Separately, TheStreet raised OraSure Technologies from a “d+” rating to a “c” rating in a research report on Wednesday, May 10th.
OraSure Technologies Stock Down 3.9 %
OSUR opened at $4.69 on Friday. OraSure Technologies has a 12-month low of $2.71 and a 12-month high of $7.82. The stock has a market cap of $343.59 million, a price-to-earnings ratio of 12.03 and a beta of 0.09. The business has a 50-day moving average of $5.60 and a 200-day moving average of $5.71.
OraSure Technologies (NASDAQ:OSUR – Free Report) last released its quarterly earnings data on Wednesday, May 10th. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.21. OraSure Technologies has a return on equity of 12.66% and a net margin of 6.16%. The company had revenue of $154.96 million during the quarter, compared to analysts’ expectations of $127.14 million. As a group, analysts expect that OraSure Technologies will post 0.19 earnings per share for the current year.
Hedge Funds Weigh In On OraSure Technologies
Hedge funds have recently bought and sold shares of the business. Ameriprise Financial Inc. grew its position in shares of OraSure Technologies by 16.4% during the 1st quarter. Ameriprise Financial Inc. now owns 456,388 shares of the medical instruments supplier’s stock worth $2,761,000 after purchasing an additional 64,182 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in OraSure Technologies by 24.5% in the 1st quarter. JPMorgan Chase & Co. now owns 128,666 shares of the medical instruments supplier’s stock valued at $779,000 after acquiring an additional 25,307 shares in the last quarter. State Street Corp lifted its position in shares of OraSure Technologies by 12.5% during the 1st quarter. State Street Corp now owns 3,010,170 shares of the medical instruments supplier’s stock valued at $18,207,000 after acquiring an additional 334,082 shares during the period. Geode Capital Management LLC lifted its position in shares of OraSure Technologies by 6.0% during the 1st quarter. Geode Capital Management LLC now owns 1,407,708 shares of the medical instruments supplier’s stock valued at $8,517,000 after acquiring an additional 79,226 shares during the period. Finally, Graham Capital Management LP grew its holdings in shares of OraSure Technologies by 161.0% during the 1st quarter. Graham Capital Management LP now owns 109,449 shares of the medical instruments supplier’s stock worth $662,000 after purchasing an additional 67,521 shares in the last quarter. 85.06% of the stock is owned by institutional investors.
OraSure Technologies Company Profile
(Free Report)
OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions.
Recommended Stories
Receive News & Ratings for OraSure Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for OraSure Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.